ECC5004 RBA FE Study in Healthy Participants
NCT06268145
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG:
ECC5004
Sponsor
Eccogene